Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Primary Sjögren's syndrome related optic neuritis.
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Multiple sclerosis: individualized disease susceptibility and therapy response.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Regulation: The FDA is overcautious on consumer genomics.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
Use of botulinum toxin for genitourinary conditions: What is the evidence?
P wave duration and dispersion and QT interval in multiple sclerosis.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Relapsing multiple sclerosis patients can look to second oral agent.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.

Pages